Increased generation of cysteinyl leukotrienes in Kawasaki disease.
Open Access
- 1 June 1995
- journal article
- research article
- Published by BMJ in Archives of Disease in Childhood
- Vol. 72 (6) , 526-527
- https://doi.org/10.1136/adc.72.6.526
Abstract
Endogenous cysteinyl leukotriene synthesis was assessed in 10 patients with Kawasaki disease and 10 healthy controls by measuring excretion of leukotriene E4 (LTE4) in urine. LTE4 was increased more than fivefold in patients with Kawasaki disease compared with controls (median (range) 55.3 (31.8-120.6) v 10.2 (7.1-14.9) nmol/mol creatinine); this suggests that cysteinyl leukotrienes are involved in the pathophysiology of Kawasaki disease. Leukotriene synthetase inhibition or receptor antagonism may therefore offer a new potential therapeutic approach in children with this disease.Keywords
This publication has 8 references indexed in Scilit:
- Leukotrienes: Biosynthesis, Metabolism, and Pathophysiologic SignificancePediatric Research, 1995
- Impaired degradation of leukotrienes in patients with peroxisome deficiency disorders.Journal of Clinical Investigation, 1993
- Increased urinary leukotriene excretion in patients with cardiac ischemia. In vivo evidence for 5-lipoxygenase activation.Circulation, 1992
- Increased in vitro Leukotriene B4 Production by Stimulated Polymorphonuclear Cells in Kawasaki DiseasePediatrics International, 1989
- Kawasaki disease: cardiac problems and management.1988
- Kawasaki Disease: Cardiac Problems and ManagementPediatrics in Review, 1988
- Increased synthesis of thromboxane A2 by platelets from patients with Kawasaki diseaseThe Journal of Pediatrics, 1983
- A New Infantile Acute Febrile Mucocutaneous Lymph Node Syndrome (MLNS) Prevailing in JapanPediatrics, 1974